BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.380
+0.123 (3.78%)
At close: Dec 5, 2025, 4:00 PM EST
3.360
-0.020 (-0.59%)
After-hours: Dec 5, 2025, 4:10 PM EST
BioLineRx Stock Forecast
BLRX's stock price has decreased by -68.72% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BioLineRx stock have an average target of 19, with a low estimate of 12 and a high estimate of 26. The average target predicts an increase of 462.13% from the current stock price of 3.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 17, 2025.
Analyst Ratings
The average analyst rating for BioLineRx stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +669.23% | Jun 17, 2025 |
| Jones Trading | Jones Trading | Hold → Strong Buy Upgrades $12 | Hold → Strong Buy | Upgrades | $12 | +255.03% | May 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +669.23% | May 28, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $26 | Strong Buy | Maintains | $9 → $26 | +669.23% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.